The androgen receptor is a tumour suppressor in estrogen receptor positive breast cancer

被引：0

作者：

Lim, Elgene ^{[1
]}

Hickey, Theresa A. ^{[2
]}

Selth, Luke A. ^{[2
]}

Chia, Kee Ming ^{[1
]}

Milioli, Heloisa H. ^{[1
]}

Roden, Daniel ^{[1
]}

Laven-Law, Geraldine ^{[2
]}

Jindal, Shalini ^{[2
]}

Hui, Mun ^{[1
]}

Ebrahimie, Esmaeil ^{[2
]}

Birrell, Stephen N. ^{[2
]}

Stelloo, Suzan ^{[3
]}

Caldon, C. Elizabeth ^{[1
]}

Finlay-Schultz, Jessica ^{[4
]}

Abdel-Fatah, Tarek M. ^{[5
]}

Ellis, Ian O. ^{[5
]}

Zwart, Willbert ^{[3
]}

Palmieri, Carlo ^{[5
]}

Sartorius, Carol A. ^{[4
]}

Swarbrick, Alex ^{[1
]}

Carroll, Jason S. ^{[6
]}

Tilley, Wayne D. ^{[2
]}

机构：

[1] Univ New South Wales, Garvan Inst Med Res, Sydney, NSW, Australia

[2] Univ Adelaide, Dame Roma Mitchell Canc Res Lab, Adelaide, SA, Australia

[3] Netherlands Canc Inst, Oncode Inst, Amsterdam, Netherlands

[4] Univ Colorado, Aurora, CO USA

[5] Univ Liverpool, Liverpool, Merseyside, England

[6] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge, England

来源：

CANCER RESEARCH | 2020年 / 80卷 / 04期

关键词：

D O I：

10.1158/1538-7445.SABCS19-GS2-03

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

GS2-03

引用

页数：2

共 50 条

[41] Androgen receptor and estrogen receptor variants in prostate and breast cancers
Lopez, Jose C. Valentin
Lange, Carol A.
Dehm, Scott M.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2024, 241
[42] Phase II Trial of Bicalutamide in Patients with Androgen Receptor-Positive, Estrogen Receptor-Negative Metastatic Breast Cancer
Gucalp, Ayca
Tolaney, Sara
Isakoff, Steven J.
Ingle, James N.
Liu, Minetta C.
Carey, Lisa A.
Blackwell, Kimberly
Rugo, Hope
Nabell, Lisle
Forero, Andres
Stearns, Vered
Doane, Ashley S.
Danso, Michael
Moynahan, Mary Ellen
Momen, Lamia F.
Gonzalez, Joseph M.
Akhtar, Arooj
Giri, Dilip D.
Patil, Sujata
Feigin, Kimberly N.
Hudis, Clifford A.
Traina, Tiffany A.
CLINICAL CANCER RESEARCH, 2013, 19 (19) : 5505 - 5512
[43] The potential clinical benefit of targeting androgen receptor (AR) in estrogen-receptor positive breast cancer cells treated with Exemestane
Amaral, Cristina
Augusto, Tiago, V
Almada, Marta
Cunha, Sara C.
Correia-da-Silva, Georgina
Teixeira, Natercia
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2020, 1866 (05):
[44] ANDROGEN RECEPTOR FUNCTIONS AS A TUMOR SUPPRESSOR IN ER+ BREAST CANCER
不详
CANCER DISCOVERY, 2021, 11 (03) : 530 - 530
[45] Progesterone Receptor Gene Variants in Metastatic Estrogen Receptor Positive Breast Cancer
Amy M. Fowler
Kelley Salem
Michael DeGrave
Irene M. Ong
Shane Rassman
Ginny L. Powers
Manoj Kumar
Ciara J. Michel
Aparna M. Mahajan
Hormones and Cancer, 2020, 11 : 63 - 75
[46] Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype
Hefti, Marco M.
Hu, Rong
Knoblauch, Nicholas W.
Collins, Laura C.
Haibe-Kains, Benjamin
Tamimi, Rulla M.
Beck, Andrew H.
BREAST CANCER RESEARCH, 2013, 15 (04)
[47] Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype
Marco M Hefti
Rong Hu
Nicholas W Knoblauch
Laura C Collins
Benjamin Haibe-Kains
Rulla M Tamimi
Andrew H Beck
Breast Cancer Research, 15
[48] Progesterone Receptor Gene Variants in Metastatic Estrogen Receptor Positive Breast Cancer
Fowler, Amy M.
Salem, Kelley
DeGrave, Michael
Ong, Irene M.
Rassman, Shane
Powers, Ginny L.
Kumar, Manoj
Michel, Ciara J.
Mahajan, Aparna M.
HORMONES & CANCER, 2020, 11 (02): : 63 - 75
[49] Progesterone receptor signaling in estrogen receptor-positive breast cancer.
Young, Amy
Guan, Jane
Daemen, Anneleen
Friedman, Lori
Lin, Kui
MOLECULAR CANCER RESEARCH, 2018, 16 (08) : 81 - 81
[50] Androgen receptor pathway activity and the ratio between androgen and estrogen receptor pathway activity in breast cancer subtypes
van de Stolpe, Anja
Wesseling-Rozendaal, Yvonne
de Inda, Marcia Alves
van Ooijen, Henk
Verhaegh, Wim
CANCER RESEARCH, 2020, 80 (04)

← 1 2 3 4 5 →